ORAL CYCLOPHOSPHAMIDE VS ORAL PLACEBO IN SYSTEM SCLEROSIS PULMONARY AVEOLITIS
ORAL CYCLOPHOSPHAMIDE VS ORAL PLACEBO IN SYSTEM SCLEROSIS PULMONARY AVEOLITIS
批准号:
7608280
负责人:
VIRGINIA D STEEN
金额:
$0.13万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-11-30
关键词:
Anti-Inflammatory AgentsAnti-inflammatoryComputer Retrieval of Information on Scientific Projects DatabaseCyclophosphamideDoseFundingGrantImmunosuppressive AgentsInstitutionKilogramLungNamesOralPatientsPharmaceutical PreparationsPlacebosReportingResearchResearch PersonnelResourcesRespiratory physiologySclerodermaSclerosisSourceSystemTabletsToxic effectUnited States National Institutes of Healthdaydesignimprovedmilligramprevent
中文摘要
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
This study has been designed to evaluate whether cyclophosphamide (a strong anti-inflammatory and immunosuppressant medication, trade named Cytoxan) is better than placebo (an inert, no effective treatment) in preventing lung damage from scleroderma from getting worse. This rail will compare 2 milligrams per kilogram per day of cyclophosphamide (approximately 100-150 mg in tablet form) with a placebo that looks like cyclophosphamide but is inert, with allowances for dose adjustments for toxicity. In previous studies from several centers, improvement in lung function was reported to have occurred after starting cyclophosphamide. In one recent study, lung function improved by greater than 10% in 3/4 of the cyclophosphamide patients and in 1/4 of the non-treated patients. This study is designed toexamine in a scientific fashion whether cyclophosphamide does actually improve lung function in people with scleroderma with early lung involvement.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EXERCISE ECHOCARDIOGRAMS IN SCLERODERMA
-
批准号:7951977
-
项目类别:
-
资助金额:$1.21万
-
财政年份:2009
-
负责人:VIRGINIA D STEEN
-
依托单位:
BOSENTAN VS PLACEBO IN NYHA CLASS I/II SCLERODERMA PATIENTS WITH EXERCISE INDUCE
-
批准号:7951985
-
项目类别:
-
资助金额:$0.35万
-
财政年份:2009
-
负责人:VIRGINIA D STEEN
-
依托单位:
EXERCISE ECHOCARDIOGRAMS IN SCLERODERMA
-
批准号:7719039
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2008
-
负责人:VIRGINIA D STEEN
-
依托单位:
SCOT
-
批准号:7719050
-
项目类别:
-
资助金额:$0.07万
-
财政年份:2008
-
负责人:VIRGINIA D STEEN
-
依托单位:
THE OUTCOME OF AFRICAN AMERICAN PATIENTS WITH SCLERODERMA IN RELATIONSHIP TO AUT
-
批准号:7719081
-
项目类别:
-
资助金额:$0.14万
-
财政年份:2008
-
负责人:VIRGINIA D STEEN
-
依托单位:
BOSENTAN VS PLACEBO IN NYHA CLASS I/II SCLERODERMA PATIENTS WITH EXERCISE INDUCE
-
批准号:7719053
-
项目类别:
-
资助金额:$0.43万
-
财政年份:2008
-
负责人:VIRGINIA D STEEN
-
依托单位:
MLN1202 IN PATIENTS WITH SCLERODERMA LUNG DISEASE
-
批准号:7608470
-
项目类别:
-
资助金额:$1.44万
-
财政年份:2007
-
负责人:VIRGINIA D STEEN
-
依托单位:
NATURAL HISTORY- SCLERODERMA & PULMONARY HYPERTENSION
-
批准号:7608467
-
项目类别:
-
资助金额:$0.43万
-
财政年份:2007
-
负责人:VIRGINIA D STEEN
-
依托单位:
TREATMENT OF SEVERE SYSTEMIC SCLEROSIS
-
批准号:7608468
-
项目类别:
-
资助金额:$0.87万
-
财政年份:2007
-
负责人:VIRGINIA D STEEN
-
依托单位:
BOSENTAN VS PLACEBO IN NYHA CLASS L/LL SCLERODERMA PATIENTSW/PULMON HYPERTENSION
-
批准号:7608469
-
项目类别:
-
资助金额:$2.19万
-
财政年份:2007
-
负责人:VIRGINIA D STEEN
-
依托单位:
EXERCISE ECHOCARDIOGRAMS IN SCLERODERMA
-
批准号:7608309
-
项目类别:
-
资助金额:$1.53万
-
财政年份:2006
-
负责人:VIRGINIA D STEEN
-
依托单位:
BOSENTAN VS PLACEBO IN NYHA CLASS I/II SCLERODERMA PATIENTS WITH EXERCISE INDUCE
-
批准号:7608329
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2006
-
负责人:VIRGINIA D STEEN
-
依托单位:
NATURAL HISTORY
-
批准号:7608319
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2006
-
负责人:VIRGINIA D STEEN
-
依托单位:
ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF BOSENTAN
-
批准号:7376138
-
项目类别:
-
资助金额:$1.29万
-
财政年份:2005
-
负责人:VIRGINIA D STEEN
-
依托单位:
EXERCISE ECHOCARDIOGRAMS IN SCLERODERMA
-
批准号:7199770
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2005
-
负责人:VIRGINIA D STEEN
-
依托单位:
ORAL CYCLOPHOSPHAMIDE VS ORAL PLACEBO IN SYSTEM SCLEROSIS PULMONARY AVEOLITIS
-
批准号:7376113
-
项目类别:
-
资助金额:$0.77万
-
财政年份:2005
-
负责人:VIRGINIA D STEEN
-
依托单位:
NATURAL HISTORY
-
批准号:7376164
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2005
-
负责人:VIRGINIA D STEEN
-
依托单位:
A MULTICENTER, PARALLEL, RANDOMIZED, CONTROLLED, ONE-YEAR STUDY OF BOVINE COL
-
批准号:7376120
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2005
-
负责人:VIRGINIA D STEEN
-
依托单位:
BOVINE COLLAGEN TYPE I VS PLACEBO IN SYSTEMIC SCLEROSIS OF 10 YEARS DURATION
-
批准号:7199768
-
项目类别:
-
资助金额:$0.87万
-
财政年份:2005
-
负责人:VIRGINIA D STEEN
-
依托单位:
EXERCISE ECHOCARDIOGRAMS IN SCLERODERMA
-
批准号:7376151
-
项目类别:
-
资助金额:$1.45万
-
财政年份:2005
-
负责人:VIRGINIA D STEEN
-
依托单位:
海外基金